Efficacy and safety of MR-107A-02 (novel fast-acting meloxicam formulation) for the treatment of acute moderate-to-severe pain following bunionectomy

Authors
Category Primary study
ConferencePAINWeek 2025 Annual Conference
Year 2025
This article has no abstract
Epistemonikos ID: cd8b5939f5e3c35c59549dbe60310223a107c511
First added on: Jan 31, 2026